Crossref

1. Low-dose Thimerosal in pediatric vaccines: Adverse effects in perspective

- José G. Dórea

2. Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations

- Beatriz Miguelena Chamorro

- Karelle De Luca

- Gokul Swaminathan

- Stéphanie Longet

- Egbert Mundt

- Stéphane Paul

3. Pertussis in Early Infancy: Diagnostic Challenges, Disease Burden, and Public Health Implications Amidst the 2024 Resurgence, with Emphasis on Maternal Vaccination Strategies

- Konstantina Leontari

- Alexandra Lianou

- Andreas G. Tsantes

- Filippos Filippatos

- Zoi Iliodromiti

- Theodora Boutsikou

- Styliani Paliatsou

- Anastasios E. Chaldoupis

- Petros Ioannou

- Alexandra Mpakosi

- Nicoletta Iacovidou

- Rozeta Sokou

4. Development and Evaluation of Five-in-One Vaccine Microneedle Array Patch for Diphtheria, Tetanus, Pertussis, Hepatitis B, and Haemophilus influenzae Type b: Immunological Efficacy and Long-Term Stability

- In-Jeong Choi

- Hye-Ran Cha

- Danbi Kwon

- Aram Kang

- Ji Seok Kim

- Jooyoung Kim

- Jeong-Eun Choi

- Hyeon Woo Chung

- Sunghoon Park

- Doo Hee Shim

- Tae-Hyun Kim

- Seung-Ki Baek

- Woon-Sung Na

- Jae Myun Lee

- Jung-Hwan Park

5. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges

- Prashant Kumar

- David A. Holland

- Kathryn Secrist

- Poorva Taskar

- Brandy Dotson

- Soraia Saleh-Birdjandi

- Yetunde Adewunmi

- Jennifer Doering

- Nicholas J. Mantis

- David B. Volkin

- Sangeeta B. Joshi

6. Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination

- I. A. Alekseeva

- O. V. Perelygina

- E. D. Kolyshkina